Research Analysis on Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016

Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016 is a new market research publication announced by Reportstack. This report provides an overview of the Vasomotor Symptoms of Menopause (Hot Flashes) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Vasomotor Symptoms of Menopause (Hot Flashes), complete with analysis by stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Vasomotor Symptoms of Menopause (Hot Flashes) and features dormant and discontinued projects.

The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

To access full report with TOC, please visit ​Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016.

Scope

- The report provides a snapshot of the global therapeutic landscape of Vasomotor Symptoms of Menopause (Hot Flashes)
- The report reviews pipeline therapeutics for Vasomotor Symptoms of Menopause (Hot Flashes) by companies and universities/research institutes based on information derived from company and industry-specific sources 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report reviews key players involved Vasomotor Symptoms of Menopause (Hot Flashes) therapeutics and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects 
- The report reviews latest news related to pipeline therapeutics for Vasomotor Symptoms of Menopause (Hot Flashes)

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Vasomotor Symptoms of Menopause (Hot Flashes)
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies 
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Companies Mentioned

Amgen Inc. EndoCeutics, Inc. Euroscreen S.A. MenoGeniX, Inc. Mithra Pharmaceuticals S.A. Pherin Pharmaceuticals, Inc. Pivot Pharmaceuticals Inc Radius Health, Inc. TherapeuticsMD, Inc.

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###